Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response

NCT03316404

CompletedN/A

Sponsor: DxTerity Diagnostics

Conditions: Multiple Sclerosis, MS

Countries: United States

To develop a test to characterize and monitor Multiple Sclerosis (MS) disease status and therapy response from a participant's home by analyzing the gene expression from participant self-collected blood samples using a novel fingerstick collection kit.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Male and female patients age 18 or older
* Have a permanent address in the United States for the duration of the study
* Have an email address and access to the internet for the duration of the study
* Able to provide informed consent
* Self-reported diagnosis of MS

Exclusion Criteria:

* None
Locations (1)
  • Compton, California, United States